JP7884738B2 - 過敏性腸症候群およびその他の末梢神経系の疾病の治療のための、末梢制限gabaアロステリック正調節因子 - Google Patents

過敏性腸症候群およびその他の末梢神経系の疾病の治療のための、末梢制限gabaアロステリック正調節因子

Info

Publication number
JP7884738B2
JP7884738B2 JP2023546485A JP2023546485A JP7884738B2 JP 7884738 B2 JP7884738 B2 JP 7884738B2 JP 2023546485 A JP2023546485 A JP 2023546485A JP 2023546485 A JP2023546485 A JP 2023546485A JP 7884738 B2 JP7884738 B2 JP 7884738B2
Authority
JP
Japan
Prior art keywords
alkyl
halo
group
compound
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023546485A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024506558A (ja
JP2024506558A5 (cg-RX-API-DMAC7.html
Inventor
フアン イファン
ジャイ パリシャ パンカジ
シー バロウ ジェイムズ
ブシュラー イングリッド
ポスラスニー マイケル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lieber Institute for Brain Development
Original Assignee
Lieber Institute for Brain Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lieber Institute for Brain Development filed Critical Lieber Institute for Brain Development
Publication of JP2024506558A publication Critical patent/JP2024506558A/ja
Publication of JP2024506558A5 publication Critical patent/JP2024506558A5/ja
Application granted granted Critical
Publication of JP7884738B2 publication Critical patent/JP7884738B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2023546485A 2021-02-02 2022-02-01 過敏性腸症候群およびその他の末梢神経系の疾病の治療のための、末梢制限gabaアロステリック正調節因子 Active JP7884738B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163144707P 2021-02-02 2021-02-02
US63/144,707 2021-02-02
PCT/US2022/014730 WO2022169758A1 (en) 2021-02-02 2022-02-01 Peripherally restricted gaba positive allosteric modulators

Publications (3)

Publication Number Publication Date
JP2024506558A JP2024506558A (ja) 2024-02-14
JP2024506558A5 JP2024506558A5 (cg-RX-API-DMAC7.html) 2025-02-27
JP7884738B2 true JP7884738B2 (ja) 2026-07-06

Family

ID=82704432

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023546485A Active JP7884738B2 (ja) 2021-02-02 2022-02-01 過敏性腸症候群およびその他の末梢神経系の疾病の治療のための、末梢制限gabaアロステリック正調節因子

Country Status (4)

Country Link
US (2) US12049467B2 (cg-RX-API-DMAC7.html)
EP (1) EP4288440A4 (cg-RX-API-DMAC7.html)
JP (1) JP7884738B2 (cg-RX-API-DMAC7.html)
WO (1) WO2022169758A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024030399A2 (en) * 2022-08-02 2024-02-08 Lab1636, Llc Use of a gaba-a pam for reduction of tactile hypersensitivity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017522371A (ja) 2014-06-26 2017-08-10 ザ・ジョンズ・ホプキンス・ユニバーシティ 過敏性腸症候群および末梢神経系の他の病気の治療のための末梢限局性gabaポジティブアロステリックモジュレーター

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450150A (en) 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US4130716A (en) 1977-03-07 1978-12-19 Hoffmann-La Roche Inc. Pyrazolo benzodiazepines
EP0523846A3 (en) * 1991-06-14 1993-03-17 Merck & Co. Inc. 1,4-benzodiazepines with 5-membered heterocyclic rings
BR0211111A (pt) 2001-07-12 2004-06-22 Univ Massachusetts Molécula de ácido nucleico isolada, vetor, célula hospedeira, transgene, precursor de rna engenheirado, animal transgênico não humano, e, método de induzir a interferência de ácido ribonucleico de um gene alvo em uma célula
US12077512B2 (en) 2019-03-25 2024-09-03 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017522371A (ja) 2014-06-26 2017-08-10 ザ・ジョンズ・ホプキンス・ユニバーシティ 過敏性腸症候群および末梢神経系の他の病気の治療のための末梢限局性gabaポジティブアロステリックモジュレーター

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
C.G.WERMUTH編,『最新 創薬化学 上巻』,株式会社テクノミック,1998年08月15日,235-271頁,13章 等価置換に基づく分子の変換
GILMAN, Norman W. et al.,"Quinazolines and 1,4‐benzodiazepines. LXXVIII Pyrazolo[1,5‐a] [1,4]‐benzodiazepines and Imidazo[1,5‐a] [1,4]benzodiazepinones",Journal of Heterocyclic Chemistry,1977年11月,Vol. 14,No. 7,p. 1163-1169,DOI: 10.1002/jhet.5570140708
KURIYAMA, K et al.,"Significance of the enhancement of GABA receptor binding with low affinity in the assessment of central effects of benzodiazepine derivatives: Analysis using a 1H-1,2,4-triazolyl benzophenone derivative (450191-S)",Neurochemistry International,1986年,Vol. 9,No. 1,p. 91-98,DOI: 10.1016/0197-0186(86)90036-7
LANGE, Jos H. M. et al.,Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists,Journal of Medicinal Chemistry,2005年,Vol.48, No.6,p.1823-1838
野崎正勝 等,創薬化学,第1版,株式会社化学同人,1995年,p.98-99

Also Published As

Publication number Publication date
JP2024506558A (ja) 2024-02-14
US20220251090A1 (en) 2022-08-11
US20250179076A1 (en) 2025-06-05
EP4288440A1 (en) 2023-12-13
US12049467B2 (en) 2024-07-30
WO2022169758A1 (en) 2022-08-11
EP4288440A4 (en) 2025-06-04

Legal Events

Date Code Title Description
A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20231115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250203

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250217

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20251016

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251021

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260121

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260316

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260602

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260615

R150 Certificate of patent or registration of utility model

Ref document number: 7884738

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150